News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
146,553 Results
Type
Article (14358)
Company Profile (12)
Press Release (132183)
Section
Business (40075)
Career Advice (210)
Deals (5399)
Drug Delivery (16)
Drug Development (18597)
Employer Resources (25)
FDA (2888)
Job Trends (3205)
News (66327)
Policy (5373)
Tag
Academia (1694)
Alliances (12676)
Alzheimer's disease (473)
Approvals (2889)
Artificial intelligence (41)
Bankruptcy (33)
Best Places to Work (2735)
Breast cancer (57)
Cancer (449)
Cardiovascular disease (27)
Career advice (195)
CAR-T (27)
Cell therapy (76)
Clinical research (14165)
Collaboration (147)
COVID-19 (1024)
C-suite (36)
Cystic fibrosis (20)
Data (340)
Diabetes (20)
Diagnostics (1585)
Drug discovery (22)
Earnings (8918)
Events (18738)
Executive appointments (100)
FDA (3045)
Funding (197)
Gene therapy (56)
GLP-1 (98)
Government (1136)
Healthcare (4959)
Infectious disease (1049)
Inflammatory bowel disease (28)
IPO (2719)
Job creations (556)
Job search strategy (185)
Layoffs (43)
Legal (948)
Lung cancer (72)
Lymphoma (29)
Manufacturing (39)
Medical device (2439)
Medtech (2439)
Mergers & acquisitions (2765)
Metabolic disorders (43)
Neuroscience (546)
NextGen: Class of 2025 (1626)
Non-profit (1948)
Northern California (343)
Opinion (45)
Parkinson's disease (22)
People (15259)
Phase I (4794)
Phase II (6506)
Phase III (4301)
Pipeline (111)
Policy (36)
Postmarket research (559)
Preclinical (2192)
Radiopharmaceuticals (46)
Rare diseases (55)
Real estate (1222)
Regulatory (3608)
Research institute (1851)
Series A (36)
Southern California (299)
Startups (1075)
United States (3353)
Vaccines (180)
Date
Last 7 days (119)
Last 30 days (326)
Last 365 days (7225)
2025 (275)
2024 (7331)
2023 (8809)
2022 (11676)
2021 (13044)
2020 (12364)
2019 (11139)
2018 (8264)
2017 (7421)
2016 (7521)
2015 (8781)
2014 (6522)
2013 (5404)
2012 (5502)
2011 (5703)
2010 (4872)
Location
Africa (189)
Alabama (25)
Arizona (43)
Asia (9139)
Australia (2042)
California (764)
Canada (269)
China (53)
Colorado (40)
Connecticut (37)
Delaware (26)
Europe (18811)
Florida (147)
Illinois (107)
Indiana (38)
Japan (24)
Maryland (123)
Massachusetts (585)
Minnesota (57)
New Jersey (327)
New York (275)
North Carolina (132)
Northern California (343)
Ohio (38)
Pennsylvania (172)
South America (250)
Southern California (299)
Texas (173)
Virginia (21)
Washington D.C. (26)
Washington State (98)
146,553 Results for "brookings institution".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
Helius Medical Technologies, Inc. today announced the expansion of the registrational program with the addition of Brooks Rehabilitation Hospital (“Brooks Rehabilitation”).
January 11, 2024
·
8 min read
Pharm Country
Brooke Eby, ALS Patient and Advocate, to deliver Keynote Address at 2024 MDA Clinical & Scientific Conference
The Muscular Dystrophy Association announced Brooke Eby will be the keynote speaker at the 2024 MDA Clinical & Scientific Conference, where she will address the world’s leaders in neuromuscular disease research and care.
February 15, 2024
·
3 min read
Business
Empress Therapeutics Appoints Virginia Finnerty-Brooks Chief Business Officer
Empress Therapeutics today announced that Virginia Finnerty-Brooks has been appointed Chief Business Officer (CBO).
December 6, 2023
·
3 min read
Drug pricing
More Than Half of IRA Negotiation Savings to Come From Three Drugs: Report
Amgen’s Enbrel, Bristol Myers Squibb’s Eliquis and Johnson & Johnson’s Stelara will account for 51.4% of the Inflation Reduction Act’s drug price negotiation savings in 2026, according to the Brookings Institution.
August 20, 2024
·
2 min read
·
Tristan Manalac
Business
Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer
Solid Biosciences Inc. today announced the appointment of Gabriel Brooks, M.D., as Chief Medical Officer.
October 2, 2023
·
5 min read
Stony Brook Study on the Role of DNA Amplification in Cancer Chemoresistance Leverages KromaTiD dGH in-Site™ Technology
A Stony Brook University team of researchers led by Gábor Balázsi , PhD, has identified DNA amplification as a major cause of drug resistance in engineered mammalian cell lines and has identified a novel approach to overcome it in those cells as well as in two human cancer cell lines.
February 6, 2024
·
2 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
Quantum Computing, Inc. Announces Collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute To Support Research Using Dirac-3 Systems
January 15, 2025
·
4 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Press Releases
ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
January 7, 2025
·
3 min read
1 of 14,656
Next
